Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - Biotronik; Concept Medical; Terumo Medical Corporation; Biosensors
- Consultant Fee/Honoraria/Speaker's Bureau - Biotronik; Biosensors; Terumo Medical Corporation; Concept Medical; Medtronic; Abbott; Medalliance